Pulmozyme dose typically can at first be 2.5 mg nebulize once a day though can vary since other variables may dictated different dosages based on the stage of the disease and/or the actual comfort level of the health care provider treating the condition. When required Pulmozyme dosage can get to 2.5 mg nebulize once a day , though it may have some different dosages One common dose of Pulmozyme happens to be 2.5 mg nebulize once a day .
An important concept is to be sure to never expect to match the dosage in mg as well as other measurement units exactly to dosage involving alternative pharmaceuticals. Matching a dosage for any one medicine vs. a amount prescribed with another medication is almost never correct. A mg measurement for one giv en medicine should never simply be compared into the same units of measurement of any other drug because potency measured on a mg for mg measurement with different pharmaceuticals can happen to be extremely variable. You can safely compare the dosage of agiven drug to recommended dosage for that given med , although not with another drugs.
For nearly all meds typically the higher the dosage more commonly a given person is to notice medicine side-effects. Pulmozyme can also be expected to not be an exception to this rule of thumb. Adverse effects which may be unusual when prescribing moderate or low Pulmozyme dose may be more usual when the actual Pulmozyme dosage is raised to a much higher Pulmozyme dose involving for example 2.5 mg nebulize once a day .
The usual route of administration of Pulmozyme is inhalation.
Whether you may be prescribed Pulmozyme on the typical starting Pulmozyme dose at 2.5 mg nebulize once a day or somewhere higher on the typical dosage range up to a FDA agreed upon highest Pulmozyme dosing of 2.5 mg nebulize once a day anyone prescribed this medication can find themselves having Pulmozyme difficulties. If anyone happens to note physical or emotional symptoms such that might be considered to be Pulmozyme consequences anyone needs to notify your doctor in order to discover whether one can continue the medication or should stop at once using the Pulmozyme.
Pulmozyme has FDA indication for use in cystic fibrosis.